Maxilene

Lidocaine, the active ingredient in Maxilene, is a local anesthetic presented as a topical preparation for skin application. It provides temporary loss of sensation and pain relief for minor skin irritations and procedures. Maxilene is intended for use on intact skin and is commonly employed in clinical and pharmacy settings.

GNH USA supplies Maxilene as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Maxilene, a topical lidocaine product, works on peripheral nerve endings to provide local anesthesia and pain relief.

- Local skin anesthesia: produces temporary numbness for minor dermatologic procedures. - Minor skin irritation pain relief: eases discomfort from insect bites, abrasions, or mild burns. - Superficial dermatologic procedures: facilitates painless application of topical treatments during skin care or minor surgical interventions.

Topical lidocaine may cause a range of skin‑related and systemic reactions.

Common Side Effects: - Localized burning or stinging sensation. - Mild erythema or redness at the application site. - Pruritus or itching. - Transient numbness extending slightly beyond the treated area. - Contact dermatitis in sensitive individuals. - Minor swelling or edema.

Serious or Rare Side Effects: - Systemic toxicity presenting as dizziness, tinnitus, or seizures. - Cardiac arrhythmias or conduction disturbances. - Severe allergic reactions including angioedema or anaphylaxis. - Methemoglobinemia causing cyanosis. - Persistent numbness or motor weakness. - Necrosis of skin with excessive or prolonged use.

When using Maxilene, consider the following safety measures.

- Assess skin integrity: avoid application on broken, infected, or inflamed skin. - Check for lidocaine allergy: discontinue use if hypersensitivity signs appear. - Limit area of application: do not exceed recommended surface area to reduce systemic absorption. - Avoid concurrent use with other topical anesthetics: may increase risk of toxicity. - Pregnancy category B1: use only when benefit outweighs potential risk. - Store at below 25°C: keep in the original container, protect from moisture and direct sunlight.

Lidocaine may interact with other medications, requiring attention to potential additive effects.

Major Interactions (Avoid): - Other amide‑type local anesthetics: concurrent use can increase systemic toxicity. - Class I antiarrhythmic drugs (e.g., quinidine, procainamide): may cause additive cardiac effects.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask early signs of lidocaine toxicity. - CYP3A4 inhibitors: can modestly raise lidocaine plasma levels. - Alcohol: may enhance central nervous system depression when combined with lidocaine.